Neurofilament protein in cerebrospinal fluid:: A marker of white matter changes

被引:156
作者
Sjögren, M
Blomberg, M
Jonsson, M
Wahlund, LO
Edman, Å
Lind, K
Rosengren, L
Blennow, K
Wallin, A
机构
[1] Res Council, Stockholm, Sweden
[2] Huddinge Univ Hosp, Neurotec Inst, Dept Geriatr Med, S-14186 Huddinge, Sweden
[3] Univ Gothenburg, Inst Clin Neurosci, Gothenburg, Sweden
关键词
white matter; dementia; axonal degeneration;
D O I
10.1002/jnr.1242
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The objective of this study was to compare cerebrospinal fluid (CSF) levels of the light subtype of the neurofilament proteins (NFL), tau, and beta -amyioid42 (A beta 42) in individuals with moderate or severe white matter changes (WMC) and in those with mild or no WMC. Twenty-two patients with Alzheimer's disease (AD), nine patients with subcortical vascular dementia (SVD), and 20 normal controls were included in the study. The occurrence of WMC was evaluated by a neuroradiologist using the Blennow-Wallin scale. Thirty-seven subjects had no or only punctate WMC 14 had moderate to severe WMC. Both diagnostic group and WMC, but not gender or apolipoproteinE E4 inheritance, contributed to the variance in the CSF levels of tau, NFL, and A beta 42. In patients with moderate to severe WMC, CSF NFL (P < 0.01), but not CSF tau or CSF A beta 42, was increased also after correction for age, gender, and degree of cognitive impairment. A comparison between patients and controls with any signs of WIVIC and those without such signs yielded a similar result: CSF NFL (P < 0.001) was increased in the group with signs of WMC. As in numerous previous studies, we found that CSF tau was increased in AD (P < 0.001) compared with controls. Furthermore, CSF NFL was increased in both AD and SVD compared with controls (P < 0.001 for both). Although diagnostic group seems to be a stronger predictor of the variance found in CSF NFL, a clear association between the presence of WIVIC and increased CSF NFL was found. Because NFL is located mainly in large myelinated axons, increased CSF NFL in individuals with WMC probably reflects axonal degeneration. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:510 / 516
页数:7
相关论文
共 59 条
  • [21] AXON CALIBER RELATED TO NEUROFILAMENTS AND MICROTUBULES IN SCIATIC NERVE FIBERS OF RATS AND MICE
    FRIEDE, RL
    SAMORAJS.T
    [J]. ANATOMICAL RECORD, 1970, 167 (04): : 379 - &
  • [22] Assessment of CSF levels of tan protein in mildly demented patients with Alzheimer's disease
    Galasko, D
    Clark, C
    Chang, L
    Miller, B
    Green, RC
    Motter, R
    Seubert, P
    [J]. NEUROLOGY, 1997, 48 (03) : 632 - 635
  • [23] High cerebrospinal fluid tau and low amyloid β42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype
    Galasko, D
    Chang, L
    Motter, R
    Clark, CM
    Kaye, J
    Knopman, D
    Thomas, R
    Kholodenko, D
    Schenk, D
    Lieberburg, I
    Miller, B
    Green, R
    Basherad, R
    Kertiles, L
    Boss, MA
    Seubert, P
    [J]. ARCHIVES OF NEUROLOGY, 1998, 55 (07) : 937 - 945
  • [24] TAU-PROTEIN AND THE NEUROFIBRILLARY PATHOLOGY OF ALZHEIMERS-DISEASE
    GOEDERT, M
    [J]. TRENDS IN NEUROSCIENCES, 1993, 16 (11) : 460 - 465
  • [25] Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease
    Green, AJE
    Harvey, RJ
    Thompson, EJ
    Rossor, MN
    [J]. NEUROSCIENCE LETTERS, 1999, 259 (02) : 133 - 135
  • [26] LEUKOARAIOSIS
    HACHINSKI, VC
    POTTER, P
    MERSKEY, H
    [J]. ARCHIVES OF NEUROLOGY, 1987, 44 (01) : 21 - 23
  • [27] Hesse Camilla, 2000, Journal of Alzheimer's Disease, V2, P199
  • [28] Iwatsubo T, 1996, AM J PATHOL, V149, P1823
  • [29] Neurofilaments in health and disease
    Julien, JP
    Mushynski, WE
    [J]. PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 61, 1998, 61 : 1 - 23
  • [30] Longitudinal study of cerebrospinal fluid levels of tau, Aβ1-40, and Aβ1-42(43) in Alzheimer's disease:: A study in Japan
    Kanai, M
    Matsubara, E
    Isoe, K
    Urakami, K
    Nakashima, K
    Arai, H
    Sasaki, H
    Abe, K
    Iwatsubo, T
    Kosaka, T
    Watanabe, M
    Tomidokoro, Y
    Shizuka, M
    Mizushima, K
    Nakamura, T
    Igeta, Y
    Ikeda, Y
    Amari, M
    Kawarabayashi, T
    Ishiguro, K
    Harigaya, Y
    Wakabayashi, K
    Okamoto, K
    Hirai, S
    Shoji, M
    [J]. ANNALS OF NEUROLOGY, 1998, 44 (01) : 17 - 26